Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Stability With 0.75% vs 0.5% Hyperbaric Bupivacaine in Cystoscopy
NCT07590544Phase 4Not yet recruiting
- Sponsor
- PAEC General Hospital
- Start
- Jul 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine, sponsored by PAEC General Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
bupivacaine
Beyond the preview
Go deeper on NCT07590544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07590544.